Short BiographyDarrin Baines is a Professor of Health Economics in the Department of Accounting, Finance & Economics, Bournemouth University.
The primary purpose of his work is to assess the impact of new technologies on population economic and social well-being using the methods and the analytical tools of economics. He usually works in interdisciplinary teams providing the economist’s point of view on technology evaluations designed to inform health systems policies and decision-making. His main areas of interest are:
- Health Technology Assessment (HTA)
- Intelligent Decision Support Systems (IDSS)
- Technology-Enabled Pharmacy (TEP)
- Pharmaceutical technology and policy
- Teaching pharmacoeconomic
In a thirty year career, Darrin has worked in banking, academia and consultancy, as well as being employed as an economist in the NHS. He gained his PhD in Economics at the University of Nottingham in 1998 researching the drivers of prescribing behaviour in general practice. After his doctoral studies, Darrin worked as a senior lecturer at the Health Services Management Centre (HSMC), University of Birmingham. Here, he worked alongside Professor Chris Ham on a number of ground-breaking evaluations of government policy reforms.
After working as a management consultant and then in the NHS, Darrin became an Associate Professor of Health Economics at Nottingham University Medical School (September 2012 to October 2014). Following this post, he became a Professor in Health Economics in the Faculty of Health and Life Sciences at Coventry University with responsibility for health economics, modelling and systems analysis within the Centre for Technology Enabled Health Research (November 2014 to March 2017). Outside of academia, Darrin is involved in a wide range of consultancy activities.
Professor Baines is a Fellow of the Royal Society of Arts (FRSA) and was recently a participant in the prestigious Royal Society Parliamentary Pairing Scheme where he was paired with Lord Prior of Brampton and his team. Currently, Darrin is a member of the International Advisory Board of the Journal of Pharmaceutical Policy and Practice.